File Ref: Enforc-11021(11)/106/2024 · CDSCO / Maharashtra FDA India's pharma industry has a brand-name problem — and a single antacid brand just showed regulators exactly why it matters. Exhibit A A Notice That Arrived Right on Time On July 6,…